07:00 , Jul 19, 2010 |  BC Week In Review  |  Company News

Radient Pharmaceuticals, Provista Diagnostics deal

Radient entered into a letter of intent to acquire Provista (also known as Provista Life Sciences LLC ) in a stock deal. Provista offers CLIA laboratory testing services, including its Biomarker Translation Test for breast...
07:00 , Jul 30, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer RAB11 family interacting protein 1 (RAB11FIP1; RCP) In vitro and mouse studies suggest that inhibiting RCP could help treat breast cancer. RCP is...
07:00 , Jul 17, 2006 |  BioCentury  |  Regulation

Opaque transparency

Officials at the National Institute for Health and Clinical Excellence, the guardians of government healthcare cost effectiveness in England and Wales, have found themselves under increasing pressure from stakeholder groups beyond the pharmaceutical industry. Hardly...
07:00 , May 8, 2006 |  BC Week In Review  |  Clinical News

BT Test: Pilot trial started

Biomarker started a pilot trial for the early detection of breast cancer through cancer-related biomarkers. Biomarker will collect blood samples from about 505 women referred for biopsy, 125 referred for other types of cancer and...
08:00 , Mar 13, 2006 |  BC Week In Review  |  Clinical News

BT Test update

Biomarker will begin this month a trial to detect breast cancer through cancer-related biomarkers. Biomarker will collect blood samples from 430 women referred for biopsy, 125 referred for other types of cancer and 300 healthy...